SCHEMBL6294686

SCHEMBL6294686

CCOC(=O)c1c(-c2ccccc2)[nH]c2ccc(F)cc2c1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.64
KMT2A Q03164 3/20 0.64
ALDH1A1 P00352 3/20 0.64
GAA P10253 2/20 0.64
MEN1 O00255 2/20 0.64
MAPT P10636 2/20 0.64
LMNA P02545 1/20 0.64
HPGD P15428 1/20 0.64
MAPK10 P53779 1/20 0.64
HSD17B10 Q99714 1/20 0.64
NPC1 O15118 1/20 0.54
TUBB4A P04350 2/20 0.53
TUBB P07437 2/20 0.53
TUBA3C P0DPH7 2/20 0.53
TUBA1B P68363 2/20 0.53
TUBA4A P68366 2/20 0.53
TUBB4B P68371 2/20 0.53
TUBB3 Q13509 2/20 0.53
TUBB2A Q13885 2/20 0.53
TUBB8 Q3ZCM7 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6295720 0.92 ALOX5 (0.54) KDM4EKMT2AALDH1A1GAAMEN1
SCHEMBL6295738 0.88 ALOX5 (0.60) KDM4EKMT2AALDH1A1GAAMEN1
SCHEMBL6295984 0.87 KDM4E (0.50) KDM4EKMT2AALDH1A1GAAMEN1
SCHEMBL6300719 0.86 ALDH1A1 (0.67) KDM4EKMT2AALDH1A1GAAMEN1
SCHEMBL6295725 0.86 CSF1R (0.71) KDM4EKMT2AALDH1A1GAAMEN1
SCHEMBL6295917 0.86 ALOX5 (0.59) KDM4EKMT2AALDH1A1GAAMEN1
SCHEMBL6300573 0.86 ALOX5 (0.58) KDM4EKMT2AALDH1A1GAAMEN1
SCHEMBL6295705 0.85 KDM4E (0.63) KDM4EKMT2AALDH1A1GAAMEN1
SCHEMBL22877730 0.84 NPC1 (0.46) KDM4EKMT2AALDH1A1GAAMEN1
SCHEMBL6295718 0.84 ALOX5 (0.62) KDM4EKMT2AALDH1A1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897316-B2 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-05-24 US disclosed
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents TP53, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHUK KDM4E 1042/4885KMT2A 780/4885ALDH1A1 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.